You are here

Arzerra

FDA Delays Ruling on Novartis’ Relapsing Multiple Sclerosis Drug

BioSpace

Wed, 06/3/20 - 11:08 am

relapsing multiple sclerosis

Novartis gets a boost in blockbuster multiple sclerosis race with Roche

Endpoints

Mon, 02/24/20 - 10:41 am

multiple sclerosis

priority reviews

Novartis takes aim at Roche's star MS drug

Reuters

Fri, 08/30/19 - 10:08 am

multiple sclerosis

Genmab hits roadblock in non-Hodgkin lymphoma

Biopharma Dive

Sat, 05/26/18 - 09:20 am

non-Hodgkin's lymphoma

clinical trials

Novartis, feeling the heat from head-to-head rivals, pulls Arzerra outside the U.S.

Fierce Pharma

Mon, 01/22/18 - 05:41 pm

chronic lymphocytic leukemia

Novartis stops PhIII trial of Genmab's Arzerra after buying rights from GSK

Fierce Biotech

Fri, 03/11/16 - 10:36 am

pemphigus vulgaris

Novartis snaps up MS indication for Glaxo's Arzerra

BioPharma Dive

Mon, 08/24/15 - 11:38 am

multiple sclerosis

Novartis files leukemia drug Arzerra in the EU

BioPharma Dive

Thu, 07/9/15 - 07:42 pm

chronic lymphocytic leukemia

GSK deal keeps paying off for Novartis with more positive Arzerra data

Fierce Pharma

Fri, 06/12/15 - 10:53 pm

chronic lymphocytic leukemia

Novartis has fresh data to support newly acquired CCL drug Arzerra

Fierce Pharma

Wed, 04/15/15 - 10:30 am

chronic lymphocytic leukemia

GSK/Genmab file Arzerra for first-line CLL

Pharma Times, UK

Mon, 10/21/13 - 09:56 am

chronic lymphocytic leukemia

GSK and Genmab Announce European Submission to Regulatory Authorities for Arzerra(R) (Ofatumumab) as 1st Line Treatment of Chronic Lymphocytic Leukemia (CLL)

Yahoo/Globe Newswire

Sat, 10/5/13 - 09:31 am

chronic lymphocytic leukemia

Is the Tide About to Turn in the Fight Against Chronic Lymphocytic Leukemia?

Motley Fool

Wed, 09/18/13 - 10:34 am

chronic lymphocytic leukemia

Breakthrough status for GSK and Genmab leukemia drug

Pharma Times, UK

Mon, 09/16/13 - 10:14 am

breakthrough therapies

chronic lymphocytic leukemia

GlaxoSmithKline and Genmab A/S submit NDA to MHLW for Arzerra

Yahoo/Fly on the Wall

Fri, 04/27/12 - 10:18 am

chronic lymphocytic leukemia

Genmab says rivals appeal U.S. ruling in patent suit

Reuters

Tue, 12/6/11 - 11:33 am

Glaxo and Genmab drop IV version of immune drug

Yahoo/AP

Thu, 09/16/10 - 12:15 pm

autoimmune disease

multiple sclerosis

Those FDA Warning Letters To Glaxo & Novartis

Pharmalot

Mon, 04/19/10 - 11:05 am

GlaxoSmithKline's Arzerra gets positive recommendation for conditional EU approval

Yahoo/AP

Fri, 01/22/10 - 10:14 am

Genmab Surges After FDA Clears Cancer Drug Shared With Glaxo

Bloomberg

Tue, 10/27/09 - 08:15 am

Pages